International Stem Cell Corporation
International Stem Cell Corporation (ISCO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ISCO · as of Jun 9, 2026
Key Statistics
Explore International Stem Cell Corporation Data
isco stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
isco competitorsISCO
BICTF
BIOR
BMNDF
CAIHF
DTRKStock Performance
Full HistoryAbout International Stem Cell Corporation
International Stem Cell Corporation (ISCO) is a clinical-stage biotechnology firm dedicated to creating therapeutic and biomedical solutions for a global market, spanning North America, Asia, Europe, …
what is international stem cell corporation · isco stock overview · international stem cell corporation company profile · who is international stem cell corporation ceo · isco OTC · international stem cell corporation headquarters · international stem cell corporation business segments
About Stock Overview & Key Data
International Stem Cell Corporation (ISCO) is a Healthcare company in the Biotechnology industry, listed on OTC since May 1, 2007. As of the latest trading session, ISCO stock price is $0.17, with a market capitalization of $1.4M. The stock has returned +30.77% over the past 12 months and +21.43% year-to-date.
In fiscal year 2025, International Stem Cell Corporation reported revenue of $9.1M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, International Stem Cell Corporation (ISCO) stock price is $0.17. The stock is traded on OTC under the ticker symbol ISCO. The 52-week range is $0.11 – $0.27.